These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 16741553)

  • 41. Renal failure in patients with cirrhosis: hepatorenal syndrome and renal support strategies.
    Meltzer J; Brentjens TE
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):139-44. PubMed ID: 20124895
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatorenal syndrome. What's new in 2007?].
    Witzke O; Gerken G; Kribben A; Philipp T
    Med Klin (Munich); 2007 Mar; 102(3):203-8. PubMed ID: 17345016
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H; Chawla Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis.
    Appenrodt B; Zielinski J; Brensing KA; Heller J; Sauerbruch T; Schepke M
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1428-32. PubMed ID: 19794309
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatorenal syndrome: do the vasoconstrictors work?
    Leung W; Wong F
    Gastroenterol Clin North Am; 2011 Sep; 40(3):581-98. PubMed ID: 21893275
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatorenal syndrome.
    Bataller R; Ginès P; Arroyo V; Rodés J
    Clin Liver Dis; 2000 May; 4(2):487-507. PubMed ID: 11232202
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatorenal syndrome: a critical update.
    Wadei HM
    Semin Respir Crit Care Med; 2012 Feb; 33(1):55-69. PubMed ID: 22447261
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
    Fagundes C; Ginès P
    Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Hepatorenal syndrome].
    Mancini E
    G Ital Nefrol; 2012; 29(5):563-78. PubMed ID: 23117737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent advances in the management of hepato-renal syndrome (HRS).
    Fabrizi F; Martin P; Messa P
    Acta Clin Belg; 2007; 62 Suppl 2():393-6. PubMed ID: 18284007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatorenal syndrome: a comprehensive overview for the critical care nurse.
    Fleming JN; Abou Abbass A
    Crit Care Nurs Clin North Am; 2010 Sep; 22(3):351-68. PubMed ID: 20691386
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatorenal Disorders.
    Al-Khafaji A; Nadim MK; Kellum JA
    Chest; 2015 Aug; 148(2):550-558. PubMed ID: 25811649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatorenal syndrome: pathogenesis and novel pharmacological targets.
    Barada K
    Curr Opin Pharmacol; 2004 Apr; 4(2):189-97. PubMed ID: 15063365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Current ascites therapy].
    Ochs A
    Praxis (Bern 1994); 1997 Jan; 86(4):94-7. PubMed ID: 9064726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.